Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Asclemed USA Inc. dba Enovachem Pharmaceuticals
FDA Inspection
•Asclemed USA Inc. dba Enovachem Pharmaceuticals•September 27, 2018

Asclemed USA Inc. dba Enovachem Pharmaceuticals – FDA Inspection, Sep 27, 2018

Record Details

This FDA Inspection record concerns Asclemed USA Inc. dba Enovachem Pharmaceuticals, with an inspection on September 27, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Asclemed USA Inc. dba Enovachem Pharmaceuticals
Inspection Date
September 27, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Rumany C. Penn (FDA Associated Person)
  • Tamara L. Ely (Issuing Officer)
View Company Profile

ID · 6f1a6e9b-11cc-426d-aea3-aaa665e9f2a9

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1067059
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

Other FDA inspections of Asclemed USA Inc. dba Enovachem Pharmaceuticals

5
DateClassificationOfficeProject area
March 5, 2025Not classifiedLos Angeles District Office
November 5, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 12, 2017Not classifiedLos Angeles District OfficeDrug Quality Assurance
July 15, 2015VAICenter for Drug Evaluation and ResearchUnapproved and Misbranded Drugs
April 18, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Asclemed USA Inc. dba Enovachem Pharmaceuticals
  • FDA Inspection 1263548 - 2025-03-05
  • FDA Inspection 1111700 - 2019-11-05
  • FDA Inspection 1029155 - 2017-10-12
  • FDA Inspection 937934 - 2015-07-15
  • FDA Inspection 828037 - 2013-04-18

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Asclemed USA Inc. dba Enovachem Pharmaceuticals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.